Home › Funds › Stephens Investment Management Group LLC › HALO

Stephens Investment Management Group LLC position in HALO

HALOZYME THERAPEUTICS INC · Health Care

Stephens Investment Management Group LLC reported holding 1,413,040 shares of HALO (HALOZYME THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$156.0M, representing 1.68% of its reported portfolio and ranking #4 among its reported holdings. Stephens Investment Management Group LLC has disclosed HALO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.41M sh
Reported value held$156.00M
Portfolio Weight1.68%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Stephens Investment Management Group LLC's HALO position evolved

Stephens Investment Management Group LLC first disclosed a stake in HALO in Q3 2023 at 1,454,707 shares (US$55.6M). The position peaked in Q3 2026 at 1,413,040 shares, worth US$156.0M. Across 13 filings, Stephens Investment Management Group LLC increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 1,413,040 shares valued at US$156.0M — an increase of 20,221 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.45M $55.57M New
Q4 2023 1.52M $56.12M Add
Q1 2024 1.55M $62.92M Add
Q2 2024 1.42M $74.45M Reduce
Q3 2024 1.36M $77.83M Reduce
Q4 2024 1.35M $64.40M Reduce
Q1 2025 1.34M $85.31M Reduce
Q2 2025 1.29M $67.21M Reduce
Q3 2025 1.23M $89.85M Reduce
Q4 2025 1.22M $82.35M Hold
Q1 2026 1.22M $78.76M Hold
Q2 2026 1.39M $109.02M Add
Q3 2026 1.41M $156.00M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HALO and 13F data

HALO (HALOZYME THERAPEUTICS INC) is a Health Care company. 44 other funds we track also report a position in HALO — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$251.9M), SNYDER CAPITAL MANAGEMENT L P (US$187.5M), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (US$178.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HALO

All HALO fund holders →

FAQ

How long has Stephens Investment Management Group LLC held HALO?

Stephens Investment Management Group LLC has disclosed HALO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Stephens Investment Management Group LLC's current position in HALO?

As of Q3 2026, Stephens Investment Management Group LLC holds 1.41M shares of HALO (HALOZYME THERAPEUTICS INC), valued at $156.00M, representing 1.68% of its reported portfolio and ranking #4.

Has Stephens Investment Management Group LLC been buying or selling HALO?

In the latest 13F filing (Q3 2026), Stephens Investment Management Group LLC increased its position in HALO. The position peaked in Q3 2026 at 1.41M shares.

Which other funds hold HALO?

Other major institutional holders of HALO include CONGRESS ASSET MANAGEMENT CO, SNYDER CAPITAL MANAGEMENT L P, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.